Generic Name: Vedolizumab
Class: Monoclonal antibody
Availability: Prescription only
Molecular Formula: C6528-H10072-N1732-O2042-S42
Substance UNII: 9RV78Q2002
What is Entyvio?
Entyvio is an integral receptor antagonist. It is the brand name of the drug vedolizumab.
What Is Entyvio Used For?
Entyvio (vedolizumab) is used for treating moderate to severe active cases of ulcerative colitis (UC) or Crohn’s disease in adults when other medications have been ineffective or when dependence on corticosteroids develops.
How Does Entyvio Work?
Entyvio helps control symptoms of ulcerative colitis and Crohn’s disease by preventing excessive amounts of white blood cells from getting into the gastrointestinal tract. These white blood cells can cause inflammation to occur in individuals who have these medical conditions.
How Long Does it Take for Entyvio to Work?
Based on clinical trials, Entyvio may take roughly 4 to 6 weeks to begin easing symptoms of ulcerative colitis or Crohn’s disease. The amount of time it takes for this medication to work can vary for each individual depending on different factors.
Do Not Use Entyvio If:
There are several situations where this medication may not be the right choice for you. According to the FDA, the following should not use Entyvio:
- Individuals with severe hypersensitivity to Entyvio or any of its ingredients. These reactions include flushing, bronchospasm, rash, increased heart rate, and urticaria.
- Individuals with active and severe infections until these are managed.
- Individuals who are exhibiting symptoms of progressive multifocal leukoencephalopathy (PML)
- Individuals with liver disease or liver injuries, since Entyvio may affect the liver
- Individuals who are not up-to-date on vaccines. Non-live vaccines may be used, but live vaccines might interact with Entyvio.
Please note that this list may not be complete, and there may be other situations where use of this drug is not advisable.